"Nanoparticles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
| Descriptor ID |
D053758
|
| MeSH Number(s) |
J01.637.512.600
|
| Concept/Terms |
Nanocrystalline Materials- Nanocrystalline Materials
- Material, Nanocrystalline
- Materials, Nanocrystalline
- Nanocrystalline Material
- Nanocrystals
- Nanocrystal
|
Below are MeSH descriptors whose meaning is more general than "Nanoparticles".
Below are MeSH descriptors whose meaning is more specific than "Nanoparticles".
This graph shows the total number of publications written about "Nanoparticles" by people in this website by year, and whether "Nanoparticles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 3 | 5 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 6 | 4 | 10 |
| 2017 | 74 | 29 | 103 |
| 2018 | 98 | 37 | 135 |
| 2019 | 40 | 11 | 51 |
| 2020 | 7 | 7 | 14 |
| 2021 | 23 | 15 | 38 |
To return to the timeline, click here.
Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay. IEEE Trans Nanobioscience. 2022 01; 21(1):37-43.
-
Virus-associated ribozymes and nano carriers against COVID-19. Artif Cells Nanomed Biotechnol. 2021 Dec; 49(1):204-218.
-
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proc Natl Acad Sci U S A. 2021 09 21; 118(38).
-
Nanoparticle-mediated surfactant therapy in patients with severe COVID-19: a perspective. J Mater Chem B. 2021 09 15; 9(35):6988-6993.
-
Triple-target stimuli-responsive anti-COVID-19 face mask with physiological virus-inactivating agents. Biomater Sci. 2021 Sep 14; 9(18):6052-6063.
-
A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2. Nanotechnology. 2021 Sep 07; 32(48).
-
A minireview on nanoparticle-based sensors for the detection of coronaviruses. Bioanalysis. 2021 Dec; 13(24):1837-1850.
-
Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target. 2022 03; 30(3):233-243.
-
Vaccine design and delivery approaches for COVID-19. Int Immunopharmacol. 2021 Nov; 100:108086.
-
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice. FEBS Lett. 2021 09; 595(18):2323-2340.